(Q51154524)

31 March 2018

title

Brain atrophy as a non-response predictor to interferon-beta in relapsing-remitting multiple sclerosis. (English)

1 reference

31 March 2018

relapsing-remitting multiple sclerosis

main subject

0 references

multiple sclerosis

0 references

author name string

Juan Ignacio Rojas

1

1 reference

31 March 2018

Liliana Patrucco

2

1 reference

31 March 2018

Jimena Miguez

3

1 reference

31 March 2018

Cristina Besada

4

1 reference

31 March 2018

Edgardo Cristiano

5

1 reference

31 March 2018

publication date

19 December 2013

1 reference

31 March 2018

published in

Neurological Research

1 reference

31 March 2018

volume

36

1 reference

31 March 2018

issue

7

1 reference

31 March 2018

page(s)

615-618

1 reference

31 March 2018

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

cites work

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

Predicting responders to therapies for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

Early predictors of non-response to interferon in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

Visual analysis of serial T2-weighted MRI in multiple sclerosis: intra- and interobserver reproducibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

Normalized accurate measurement of longitudinal brain change.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

Accurate, robust, and automated longitudinal and cross-sectional brain change analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

Adherence level and knowledge about psychopharmacological treatment among patients discharged from psychiatric internment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

Magnetic Resonance Techniques in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

The contribution of MRI in assessing cognitive impairment in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2F1743132813Y.0000000304

10.1179/1743132813Y.0000000304

21 January 2018

Identifiers

DOI

1 reference

31 March 2018

1 reference

31 March 2018